Graypoint LLC Buys 1,152 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Graypoint LLC grew its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 73,312 shares of the real estate investment trust’s stock after acquiring an additional 1,152 shares during the quarter. Graypoint LLC’s holdings in Omega Healthcare Investors were worth $2,775,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Daiwa Securities Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 317.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after purchasing an additional 3,003,845 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Omega Healthcare Investors by 328.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after buying an additional 1,274,238 shares in the last quarter. Marshall Wace LLP bought a new position in Omega Healthcare Investors in the second quarter valued at about $20,962,000. FMR LLC raised its stake in Omega Healthcare Investors by 9.9% during the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after acquiring an additional 380,626 shares in the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of Omega Healthcare Investors by 441.4% in the third quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock worth $17,177,000 after acquiring an additional 350,570 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Trading Down 2.6 %

NYSE OHI traded down $1.00 during trading hours on Friday, hitting $36.83. 2,322,140 shares of the company’s stock were exchanged, compared to its average volume of 1,717,206. The firm has a market cap of $9.94 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 1.22 and a beta of 0.99. The stock has a 50-day simple moving average of $39.25 and a 200 day simple moving average of $38.63. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 7.28%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on OHI. Royal Bank of Canada upped their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target for the company in a research note on Monday, December 9th. Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a research report on Thursday, October 31st. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $40.18.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.